Highlander Capital Management’s Zimmer Biomet ZBH Stock Holding History

Highlander Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$791K	Buy	5,996 +200	+3%	+$25K	0.27%	87
2023 Q4	$705K	Hold	5,796	–	–	0.25%	89
2023 Q3	$650K	Hold	5,796	–	–	0.26%	86
2023 Q2	$844K	Hold	5,796	–	–	0.39%	58
2023 Q1	$749K	Hold	5,796	–	–	0.37%	66
2022 Q4	$739K	Hold	5,796	–	–	0.39%	59
2022 Q3	$606K	Hold	5,796	–	–	0.35%	66
2022 Q2	$609K	Hold	5,796	–	–	0.33%	69
2022 Q1	$741K	Sell	5,796 -174	-3%	-$21K	0.35%	68
2021 Q4	$736K	Hold	5,970	–	–	0.34%	68
2021 Q3	$848K	Hold	5,970	–	–	0.43%	55
2021 Q2	$932K	Hold	5,970	–	–	0.47%	54
2021 Q1	$928K	Hold	5,970	–	–	0.49%	51
2020 Q4	$893K	Hold	5,970	–	–	0.5%	46
2020 Q3	$789K	Hold	5,970	–	–	0.48%	48
2020 Q2	$692K	Hold	5,970	–	–	0.44%	56
2020 Q1	$586K	Hold	5,970	–	–	0.42%	57
2019 Q4	$868K	Hold	5,970	–	–	0.5%	55
2019 Q3	$796K	Hold	5,970	–	–	0.49%	56
2019 Q2	$682K	Hold	5,970	–	–	0.41%	65
2019 Q1	$740K	Sell	5,970 -1,526	-20%	-$173K	0.46%	59
2018 Q4	$747K	Hold	7,496	–	–	0.49%	54
2018 Q3	$957K	Sell	7,496 -155	-2%	-$18.4K	0.53%	48
2018 Q2	$828K	Buy	7,651 +155	+2%	+$16.9K	0.47%	61
2018 Q1	$780K	Buy	7,496 +4,072	+119%	+$473K	0.46%	64
2017 Q4	$401K	Hold	3,424	–	–	0.29%	93
2017 Q3	$389K	Buy	3,424 +618	+22%	+$71.3K	0.3%	92
2017 Q2	$350K	Hold	2,806	–	–	0.27%	95
2017 Q1	$333K	Sell	2,806 -103	-4%	-$11.7K	0.27%	99
2016 Q4	$291K	Hold	2,909	–	–	0.25%	112
2016 Q3	$367K	Hold	2,909	–	–	0.33%	83
2016 Q2	$340K	Hold	2,909	–	–	0.31%	91
2016 Q1	$301K	Hold	2,909	–	–	0.28%	101
2015 Q4	$290K	Buy	2,909 +515	+22%	+$50.4K	0.27%	105
2015 Q3	$218K	Hold	2,394	–	–	0.21%	132
2015 Q2	$254K	Hold	2,394	–	–	0.23%	113
2015 Q1	$273K	Hold	2,394	–	–	0.24%	110
2014 Q4	$264K	Buy	2,394 +1,092	+84%	+$115K	0.23%	115
2014 Q3	$127K	Hold	1,302	–	–	0.12%	190
2014 Q2	$131K	Hold	1,302	–	–	0.12%	196
2014 Q1	$120K	Hold	1,302	–	–	0.11%	196
2013 Q4	$118K	Hold	1,302	–	–	0.11%	206
2013 Q3	$104K	Hold	1,302	–	–	0.1%	217
2013 Q2	$94.7K	Buy	+1,302	New	+$97.4K	0.1%	227

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highlander Capital Management's ZBH Position: Q1 2024 in Review

Highlander Capital Management increased its Zimmer Biomet (ZBH) stake by 3.5% in Q1 2024, buying an estimated $25K and bringing the position to 5,996 shares worth $791K. The position accounts for 0.27% of the portfolio, ranked #87.

Highlander Capital Management first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $957K in Q3 2018. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

Highlander Capital Management held 5,996 shares of Zimmer Biomet worth $791K as of Q1 2024.
Highlander Capital Management bought 200 Zimmer Biomet shares in Q1 2024, an estimated $25K.
Zimmer Biomet made up 0.27% of Highlander Capital Management's portfolio in Q1 2024, its #87 holding.
Highlander Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
Highlander Capital Management's Zimmer Biomet position peaked at $957K in Q3 2018.
1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.